about
Origins of lymphatic and distant metastases in human colorectal cancer.MET Amplification in Esophageal Squamous CarcinomaMET Alterations are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung CancerTAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic CholangiocarcinomaTreatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation DiversitySerial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal CancersIntegrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer
P50
Q38373329-3956D10C-20CE-447C-B761-E2386D992B33Q88094369-A6FE1FD5-3CD3-4278-BD8F-BD9C9420B5D2Q89837824-0B4B295C-4479-4147-B882-8B0AD33A2150Q92169606-5424E74C-30BD-4217-9FFF-B54CCA9C619AQ92264237-82B712B6-747B-4E90-B87F-89B66B745FB6Q92668417-AA88616D-AA12-4EE9-A943-BED9F9020FB8Q93115049-6D780DED-7BED-46CA-8721-32E9ECD04F3A
P50
description
researcher
@en
wetenschapper
@nl
name
Jochen K Lennerz
@en
Jochen K Lennerz
@nl
type
label
Jochen K Lennerz
@en
Jochen K Lennerz
@nl
prefLabel
Jochen K Lennerz
@en
Jochen K Lennerz
@nl
P31
P496
0000-0003-2434-4978